A Single Collaborative Platform to Trace, Build, Protect, and Share Bio-innovation

From early research to commercialisation, GitLife brings structure, traceability, and security at every step of development.

Biotech is becoming programmable. IP should be too.

At GitLife, we believe synthetic biology deserves better tools — not just to build things faster, but to own and commercialise them smarter. We understand the critical challenges facing the synthetic biology industry, such as IP protection, biosecurity risks, and regulatory uncertainty, which can hinder innovation and collaboration.

We’re building the IP layer for biology — merging the rigour of software versioning with the flexibility of the lab bench.

Whether you’re an early-stage founder, research lead, or commercial exec, GitLife helps you transform biological work into structured, living IP.

Protect Innovation Prevent IP Loss

Trace every bioasset from creation to collaboration and commercialisation with biological version control, and embedded barcode (Genosignatures™) — so your innovations can’t walk out the door.

Prevent IP leakage, unauthorised reuse, and ensure biosecurity is embedded at every step.

Unlock Revenue from Hidden IP

Link licensing terms, usage rights, and ownership directly to biological assets — making it easy to track value, enforce deals, and stop underutilised IP from going to waste.

 Never miss a milestone, licence, or opportunity to monetise.

Collaborate Without Compromise

Enable secure, auditable collaboration across teams and partners — with full lineage tracking, contribution logs, and compliance-ready records from day one.

 

Work together without duplication, confusion, or risk.

Introducing:

The preeminent biotech solution for strain management in synthetic biology. CellRepo™  is an advanced version control and biosecurity system that catalogues and secures digital information generated throughout the strain engineering process.

 Acting as a digital platform, CellRepo™ organises the wealth of data generated during cell engineering processes, fostering transparency and responsibility in research procedures. Put simply, CellRepo™ is best in class.

Upon request, CellRepo™ has the capability to generate a unique DNA Genosignature® for each digital entry. This physically links cell samples with digital records of their construction and ownership, crucial for asserting intellectual property rights.

Our innovative Genosignature® technology ensures a seamless link between digital data and corresponding living samples, enhancing traceability which is essential for intellectual property rights.

Achieve scientific breakthroughs effortlessly while ensuring data security and compliance.

Elevate your research with CellRepo™ , the leader in version control for cell editing.

Newcastle University Spin-Out

Led by leading synthetic biology and computer science academics in partnership with dynamic entrepreneurs

We are a proud spin-out from the ICOS Research Group at Newcastle University. Having roots in this world-class research environment and by combining cutting-edge research with innovative business acumen, we have had a strong foundation for developing groundbreaking technologies like the CellRepo™ platform and GenoSignature® technology.

Meet Our Team.

Our team is composed of leading experts in synthetic biology, genetic and cell engineering, and biological asset management. With diverse backgrounds and extensive expertise, we are committed to driving innovation in DNA barcodes and biotechnology solutions to advance the global standards of biological asset management and revolutionise the biotech industry as a leading synthetic biology company.

Our Products: Trackable. Shareable. Protected.

Pioneering Biological Rights & IP Management

Just as digital rights management transformed software, GitLife leading the way in

Biological rights and IP Management—the process of tracking, securing, and verifying the

provenance, ownership, and usage of engineered biological materials.

Our platform is powered by two core technologies: CellRepo, a version-controlled bioasset registry, and Genosignatures, encrypted DNA barcodes for physical IP traceability

CellRepo®

The Bioasset Registry with Version Control

A Git-style platform that lets you barcode, track, and version biological assets — from engineered strains to protocols and constructs.

“CellRepo is version control for biology — everything tracked, nothing lost.”

Genosignatures™

DNA-Level barcoding for IP Traceability

Encrypted, embedded DNA barcodes link engineered organisms directly to their CellRepo records — enhancing IP provenance and commercial protection.

“Genosignatures make your biological IP verifiable, portable, and enforceable.”

Use Case Highlights

  • For Heads of Synthetic Biology
    •   Own your data. Accelerate commercialisation.
  • For Commercial Lead
    •  Instantly see what’s valuable, licensed, or restricted.
  • For Biotech Startups
    • Build IP infrastructure from day one.
  • For Scientists
    • Know what’s been done by who— and what’s worth doing next.

Biosecurity built in.

Traceable biology, cryptographic watermarking, and IP governance — from day one. 

Ready to organise your biotech innovations?

Whether you’re structuring your first strain registry or prepping for a licensing deal, GitLife makes it easy to track, protect, and scale your biological assets.